Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport Long-Term Extension in Upper Limb Spasticity
NCT01313312Phase 3Completed
- Sponsor
- Ipsen
- Start
- Nov 2011
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of abobotulinumtoxinA in Upper limb spasticity, sponsored by Ipsen. Started Nov 2011; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT01313312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313312.